Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 131,229
  • Shares Outstanding, K 170,738
  • Annual Sales, $ 126,330 K
  • Annual Income, $ -113,720 K
  • EBIT $ -140 M
  • EBITDA $ -132 M
  • 60-Month Beta 2.06
  • Price/Sales 0.99
  • Price/Cash Flow N/A
  • Price/Book 5.21
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.14
  • Most Recent Earnings $-0.33 on 11/13/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 192.20% ( +27.00%)
  • Historical Volatility 103.81%
  • IV Percentile 61%
  • IV Rank 26.40%
  • IV High 652.30% on 04/17/24
  • IV Low 27.12% on 01/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 506
  • Volume Avg (30-Day) 1,733
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 47,831
  • Open Int (30-Day) 32,324

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 3
  • High Estimate -0.13
  • Low Estimate -0.22
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +43.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5406 +42.18%
on 11/18/24
0.8845 -13.10%
on 11/20/24
-0.0139 (-1.78%)
since 10/22/24
3-Month
0.5406 +42.18%
on 11/18/24
1.3200 -41.77%
on 09/06/24
-0.0914 (-10.63%)
since 08/22/24
52-Week
0.5400 +42.33%
on 04/19/24
2.0500 -62.51%
on 01/09/24
-0.3514 (-31.38%)
since 11/22/23

Most Recent Stories

More News
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

MCRB : 0.7686 (+5.03%)
Seres Therapeutics: Q3 Earnings Snapshot

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.7686 (+5.03%)
Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

MCRB : 0.7686 (+5.03%)
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024

MCRB : 0.7686 (+5.03%)
Seres Therapeutics: Q2 Earnings Snapshot

Seres Therapeutics: Q2 Earnings Snapshot

MCRB : 0.7686 (+5.03%)
Seres Therapeutics: Q1 Earnings Snapshot

Seres Therapeutics: Q1 Earnings Snapshot

MCRB : 0.7686 (+5.03%)
Seres Therapeutics: Q3 Earnings Snapshot

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.7686 (+5.03%)
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 24.69 (+1.94%)
FHTX : 7.84 (+1.55%)
MRNA : 41.11 (+7.48%)
OMGA : 0.7860 (+1.29%)
SANA : 2.61 (+11.06%)
MCRB : 0.7686 (+5.03%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFoundâ„¢ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 24.69 (+1.94%)
FHTX : 7.84 (+1.55%)
MRNA : 41.11 (+7.48%)
OMGA : 0.7860 (+1.29%)
SANA : 2.61 (+11.06%)
MCRB : 0.7686 (+5.03%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 24.69 (+1.94%)
FHTX : 7.84 (+1.55%)
MRNA : 41.11 (+7.48%)
OMGA : 0.7860 (+1.29%)
SANA : 2.61 (+11.06%)
MCRB : 0.7686 (+5.03%)

Business Summary

Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 0.8523
2nd Resistance Point 0.8167
1st Resistance Point 0.7926
Last Price 0.7686
1st Support Level 0.7329
2nd Support Level 0.6973
3rd Support Level 0.6732

See More

52-Week High 2.0500
Fibonacci 61.8% 1.4732
Fibonacci 50% 1.2950
Fibonacci 38.2% 1.1168
Last Price 0.7686
52-Week Low 0.5400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar